Facebook feeling the heat as investors look into russian meddling in the u. S. President ial election. Fbn am starts right now. It is 5 01 a. M. In new york city on monday september 18th. Im Lea Gabrielle in for cheryl casone. Lauren happy monday. Im lauren simonetti. We begin with President Trump said to make his first address to the United Nations. White House National security advisor h. R. Mcmaster saying the president thinks the speech is a tremendous opportunity to reach so many world leaders. First is to protect the American People will in the third is really to help promote accountability and sovereignty. Those three things allow him to communicate his vision for americas role in the world peered lauren today the president will have several meetings with Benjamin Netanyahu and emanuel machrone writes your new york. Lea the president see says they intensified. Ambassador to the u. N. Mcneely says the security is running out of options. We were trying to use every diplomatic poss
Forefront Analytics LLC boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 319 shares of the biopharmaceutical company’s stock after buying an additional 26 shares during the period. Forefront Analytics LLC’s […]
Rhenman & Partners Asset Management AB reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,000 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the […]
Rhenman & Partners Asset Management AB reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,000 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) Director Michael S. Brown sold 1,172 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $974.86, for a total value of $1,142,535.92. Following the completion of the sale, the director now directly owns […]